Alex Sapir

2017

In 2017, Alex Sapir earned a total compensation of $6M as President and Chief Executive Officer at Dova Pharmaceuticals.

Compensation breakdown

Bonus$20,000
Non-Equity Incentive Plan$180,000
Option Awards$5,414,664
Salary$400,077
Other$2,002
Total$6,016,743

Sapir received $5.4M in option awards, accounting for 90% of the total pay in 2017.

Sapir also received $20K in bonus, $180K in non-equity incentive plan, $400.1K in salary and $2K in other compensation.

Rankings

In 2017, Alex Sapir's compensation ranked 1,458th out of 14,666 executives tracked by ExecPay. In other words, Sapir earned more than 90.1% of executives.

ClassificationRankingPercentile
All
1,458
out of 14,666
90th
Division
Manufacturing
492
out of 5,768
92nd
Major group
Chemicals And Allied Products
130
out of 2,074
94th
Industry group
Drugs
93
out of 1,730
95th
Industry
Pharmaceutical Preparations
72
out of 1,329
95th
Source: SEC filing on April 27, 2018.

Sapir's colleagues

We found two more compensation records of executives who worked with Alex Sapir at Dova Pharmaceuticals in 2017.

2017

Lee Allen

Dova Pharmaceuticals

Chief Medical Officer

2017

Douglas Blankenship

Dova Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like